ServiceNow Series E197: Peter Oneppo, CEO and Co-Founder and Juan Antonio Villagomez, Director of Engineering at Serenity

ServiceNow Series E197: Peter Oneppo, CEO and Co-Founder and Juan Antonio Villagomez, Director of Engineering at Serenity

Author: Alldus International April 7, 2025 Duration: 20:07

Today's guests are Peter Oneppo, CEO and Co-Founder and Juan Antonio Villagomez, Director of Engineering at Serenity. Founded in 2019 by a team of former ServiceNow product and sales leaders passionate about driving operational excellence on the ServiceNow platform, Serenity was created to empower teams to streamline their workflows so they can focus on the things that matter most: culture, happiness, engagement and growth.Serenity offers the only AI-powered EHS solutions natively built on ServiceNow. They empower companies to enhance efficiency, ensure compliance and prioritize employee well-being, while also safeguarding their brand reputation. Seamlessly integrating into a trusted business platform, Serenity’s solutions streamline operational workflows, optimize processes and elevate data visibility - driving organizations toward true operational excellence.In the episode, Peter and Juan Antonio discuss:

0:00 Peter and Juan Antonio’s journey within ServiceNow and building Serenity EHS

4:15 Simplifying EHS management on ServiceNow

8:10 Use case of helping a customer streamline legacy apps on ServiceNow

9:50 Focus on improving product adoption, AI and workplace safety

11:57 How Series A funding boosts platform consolidation, AI and user experience

14:22 Their collaborative, innovative culture focused on customer experience and teamwork

16:05 Offering flexibility, growth, work-life balance and remote cultureTo find out more about all the great work happening at Serenity, check out the website www.serenityehs.com


Behind the buzzwords and headlines, artificial intelligence is already reshaping industries and daily routines in tangible ways. The Alldus Podcast-AI in Action cuts through the noise to focus on these real-world applications. Each conversation goes beyond theory, delving into the practical challenges and triumphs experienced by the people building and implementing these technologies. You’ll hear directly from technologists and data science practitioners who are on the front lines, discussing the specific impact of Data Science, Machine Learning, and AI on everything from healthcare and finance to how we interact with the world around us. This series, supported by Alldus International’s work in AI workforce solutions, is built on a simple idea: understanding comes from listening to those doing the work. The discussions are grounded in current projects and genuine expertise, offering a clear-eyed view of what’s possible now and what might be next. Tune in for a candid exploration of how intelligent systems are being put into action, moving from conceptual hype to functional reality. This podcast provides a essential perspective for anyone curious about the practical engine driving technological change today.
Author: Language: en-us Episodes: 100

The Alldus Podcast - AI in Action
Podcast Episodes
E550 Shayde Christian, Chief Data & Analytics Officer at Cloudera [not-audio_url] [/not-audio_url]

Duration: 24:10
Today's guest is Shayde Christian, Chief Data & Analytics Officer at Cloudera. Founded in 2008, Cloudera believes that data can make what is impossible today, possible tomorrow. They empower people to transform complex d…
E549 Dave DeCaprio, CTO at mbue [not-audio_url] [/not-audio_url]

Duration: 20:44
Today's guest is Dave DeCaprio, CTO at mbue. Founded in 2022, mbue helps Architecture, Engineering and Construction firms build better businesses by providing AI-based quality control tools. Their product is a web based…
E548 Brandon Rice, Chief Product Officer at Weave [not-audio_url] [/not-audio_url]

Duration: 25:48
Today's guest is Brandon Rice, Chief Product Officer at Weave. Founded in 2023, Weave Bio is an AI-native regulatory automation management platform redefining regulatory submissions for novel therapeutic candidates. Desi…